Chris Aiken, MD

Pregnancy and PMDD at the Mood Summit

December 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

This podcast brings you up to date on how to manage premenstrual dysphoric disorder and safe prescribing during pregnancy.

Antidepressants and Bipolar at the Mood Summit

November 21, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Dr. Joe Goldberg gathered the latest evidence on antidepressants in bipolar disorder at the 9th annual Mood Disorders Summit, and we summarize his findings.

Throwback Thursday: Lithium’s Medical Benefits

November 10, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Lithium has hidden health benefits against stroke, cancer, dementia, and even the coronavirus.

Psychopharm Commandment 5: Benzos Opioids

November 7, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Benzos are never safe with opioids, but we clarify when the risk is lower and when the combo is best avoided.

The Benzodiazepine-Stimulant Combo: What Could Go Wrong?

September 25, 2022

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Neurotoxicity, substance use disorders, even traffic accidents can arise from this controversial combination. We look at how to handle it in practice, including how to reduce the use and when the combination might be OK to continue.

CLINICAL UPDATE

A Diet for ADHD

September 25, 2022

Chris Aiken, MD and Uma Naidoo, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.

Uma Naidoo, MD. Director of Nutritional and Metabolic Psychiatry, Massachusetts General Hospital (MGH); Director of Nutritional & Lifestyle Psychiatry, MGH Academy; Author, This Is Your Brain on Food (Little, Brown Spark; 2020).

The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

After years of suggestive studies, the first randomized controlled to test a practical approach to diet in ADHD is out. Find out which foods to eat, and which to avoid.

Expert Q&A

Advances in College Mental Health

September 2, 2022

Michelle Riba MD, Garrett Rossi, MD., and Chris Aiken, MD

Michelle B. Riba, MD, MS

Professor, Department of Psychiatry; Co-Director, Workplace Mental Health Solutions, Eisenberg Family Depression Center; Director, PsychOncology Program, University of Michigan Rogel Cancer Center. Editor, College Psychiatry: Strategies to Improve Access to Mental Health (co-editor: Meera Menon, MD).

Interview by Garrett Rossi, MD. Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Dr. Riba, expert of this educational activity, has disclosed that she receives book royalties from Springer, Wiley, and APA Publishing. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship. Dr. Rossi has no relevant financial relationship(s) with ineligible companies to disclose.

College life is not what it used to be, and Dr. Riba shares ways to improve psychiatric care for students facing COVID lockdowns, financial strain, and the contagion of campus suicide.

In Brief

Sexual Activity on the Decline

September 1, 2022

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

What are the clinical implications of the largest and broadest study that shows declining sexual activity in the past decade?

What Gets in the Way of Antidepressants?

August 1, 2022

Chris Aiken, MD and Garrett Rossi, MD.

Garrett Rossi, MD.
Inpatient/consult attending psychiatrist, AtlantiCare Regional Medical Center, Pomona, NJ.

Chris Aiken, MD.
Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.

Dr. Rossi and Dr. Aiken, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Recent research has added to our understanding of factors that inhibit response to treatment, including major stress, nonadherence, and anxiety.

Five New Findings in Psychopharmacology

July 4, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Bupropion-dextromethorphan combo in depression. Lithium for COVID-19. The top med for nicotine cessation. Mirtazapine in OCD. Mediterranean diet in depression.